OSMT - Osmotica Pharmaceuticals plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Osmotica Pharmaceuticals plc

400 Crossing Boulevard
Bridgewater, NJ 08807
United States
908-809-1300
http://www.osmotica.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees466

Key Executives

NameTitlePayExercisedYear Born
Mr. Brian A. MarkisonChairman, Pres & CEO1.11MN/A1959
Mr. Andrew J. EinhornChief Financial Officer505.07kN/A1960
Dr. Tina Marie deVriesExec. VP of R&D551.38kN/A1961
Mr. James D. SchaubExec. VP & COON/AN/A1982
Mr. Christopher A. KleinGen. Counsel & Sec.N/AN/A1964
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations. The company's promoted approved products include specialty neurology products, such as M-72 to treat attention deficit hyperactivity disorder (ADHD); Osmolex ER for treating Parkinson's and drug-induced extrapyramidal reactions in adults; Lorzone for muscle spasms; ConZip to treat pain; and Ontinua ER for treating opioid withdrawal symptoms. It also provides women's health products, including Divigel for menopause, as well as OB Complete, a dietary supplement for prenatal, pregnancy, and postnatal periods; and RVL-1201 for treating Blepharoptos. In addition, the company's non-promoted approved products comprise Methylphenidate ER for ADHD; Venlafaxine ER tablets to treat major depressive disorder and social anxiety disorder; Hydromorphone ER for treating; Nifedipine ER for hypertension; Sodium Benzoate/Sodium Phenylacetate to treat hyperammonemia; Oxybutynin ER for overactive bladder; and prescription prenatal vitamins for treating nutritional requirements during pregnancy, as well as Osmodex and other abbreviated new drug applications. Osmotica Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

Corporate Governance

Osmotica Pharmaceuticals plc’s ISS Governance QualityScore as of October 4, 2019 is 8. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 4; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.